Home › Asset managers › Compare 2024-2025 › BlackRock vs Dimensional
BlackRock 2024-2025 · Dimensional 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 14,294 | 12,672 | 1,294 | 328 | 90.7% | 90.0% |
| Board proposals | 11,461 | 10,148 | 1,113 | 200 | 90.1% | 89.5% |
| E&S shareholder proposals | 233 | 160 | 1 | 72 | 99.4% | 92.5% |
| Other items | 2,600 | 2,364 | 180 | 56 | 92.9% | 91.8% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
1,313 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | BlackRock | Dimensional |
|---|---|---|---|---|---|---|
| HURON CONSULTING GROUP INC. | May 9, 2025 | To approve an amendment to the Company's Amended and Restated 2012 Omnibus Incentive Plan. Compensation |
Board | For | FOR 14 funds |
AGAINST 18 funds |
| HYLIION HOLDINGS CORP. | May 20, 2025 | To approve, on an advisory basis, compensation for the Company's named executive officers, as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 12 funds |
AGAINST 11 funds |
| IBIO INC. | November 21, 2024 | To approve, on an advisory, non-binding basis, the compensation of our named executive officers ("say-on-pay"). Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 3 funds |
| ICHOR HOLDINGS LTD. | May 14, 2025 | To approve the adoption of the Ichor Holdings, Ltd. 2025 Omnibus Incentive Plan. Compensation |
Board | For | FOR 17 funds |
AGAINST 21 funds |
| IDEAL POWER INC. | June 12, 2025 | Approval, on a non-binding, advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| IES HOLDINGS INC. | February 20, 2025 | ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION. Say-on-Pay |
Board | For | FOR 25 funds |
AGAINST 18 funds |
| IF BANCORP INC | November 25, 2024 | An advisory, non-binding resolution to approve the Company's executive compensation as described in the proxy statement. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 9 funds |
| IMPERIAL OIL LIMITED | May 8, 2025 | Election of Director: M.C. (Miranda) Hubbs Director Elections |
Board | For | FOR 14 funds |
AGAINST 14 funds |
| INCYTE CORP. | June 10, 2025 | Approve amendments of the Company's Amended and Restated 2010 Stock Incentive Plan. Compensation |
Board | For | FOR 56 funds |
AGAINST 3 funds |
| INDIE SEMICONDUCTOR INC. | June 4, 2025 | To approve an amendment to the 2021 Omnibus Equity Incentive Plan to increase the number of shares of Class A Common Stock reserved for issuance thereunder by 17,000,000 shares. Compensation |
Board | For | FOR 11 funds |
AGAINST 8 funds |
| INFORMATION SERVICES GROUP INC. | April 24, 2025 | To approve, in a non-binding advisory vote, the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | FOR 13 funds |
AGAINST 17 funds |
| INFUSYSTEM HOLDINGS INC. | May 15, 2025 | Approval, on advisory basis, of the Company's Executive Compensation. Say-on-Pay |
Board | For | FOR 10 funds |
AGAINST 17 funds |
| INGLES MARKETS INC. | March 3, 2025 | To approve, by non-binding vote, executive compensation, as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 24 funds |
AGAINST 22 funds |
| INMUNE BIO INC. | June 10, 2025 | To approve the Second Amended and Restated INmune Bio Inc. 2021 Stock Incentive Plan. Compensation |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| INNOVATE CORP. | June 12, 2025 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers (the "Say on Pay Vote"). Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| INNOVATIVE INDUSTRIAL PROPERTIES INC. | June 11, 2025 | Approval on a non-binding advisory basis of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 32 funds |
AGAINST 2 funds |
| INNOVEX INTERNATIONAL INC. | May 14, 2025 | To adopt the Company's 2025 Long-Term Incentive Plan. Compensation |
Board | For | FOR 14 funds |
AGAINST 19 funds |
| INOGEN INC. | May 14, 2025 | To approve, on an advisory and non-binding basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 14 funds |
AGAINST 15 funds |
| INOVIO PHARMACEUTICALS INC. | May 20, 2025 | To approve, on a non-binding advisory basis, the resolution regarding compensation of our named executive officers described in the accompanying proxy statement. Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 4 funds |
| INTAPP INC. | November 13, 2024 | To conduct an advisory vote to approve named executive officer compensation ("Say-On-Pay Vote"). Say-on-Pay |
Board | For | FOR 28 funds |
AGAINST 13 funds |
| INTEL CORP. | May 6, 2025 | Advisory vote on executive compensation (Say-On-Pay). Say-on-Pay |
Board | For | FOR 71 funds |
AGAINST 17 funds |
| INTEL CORP. | May 6, 2025 | Approval of amendment and restatement of the 2006 Equity Incentive Plan. Compensation |
Board | For | FOR 53 funds |
AGAINST 16 funds |
| INTELLIA THERAPEUTICS INC. | June 11, 2025 | Approval of the Intellia Therapeutics, Inc. 2025 Equity Incentive Plan. Compensation |
Board | For | FOR 18 funds |
AGAINST 4 funds |
| INTELLIA THERAPEUTICS INC. | June 11, 2025 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers ("NEOs"). Say-on-Pay |
Board | For | FOR 31 funds |
AGAINST 5 funds |
| INTELLIA THERAPEUTICS INC. | June 11, 2025 | Election of three class III directors to our board of directors, each to serve until the 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal. William Chase Director Elections |
Board | For | FOR 18 funds |
AGAINST 4 funds |
| INTELLIGENT PROTECTION MANAGEMENT CORP. | May 8, 2025 | To approve the Intelligent Protection Management Corp. 2025 Long-Term Incentive Plan. Compensation |
Board | For | FOR 1 fund |
AGAINST 4 funds |
| INTERACTIVE BROKERS GROUP INC. | April 17, 2025 | To approve, by non-binding vote, executive compensation. Say-on-Pay |
Board | For | FOR 47 funds |
AGAINST 11 funds |
| INTERNATIONAL FLAVORS & FRAGRANCES INC. | May 1, 2025 | Approve, on an advisory basis, the compensation of our named executive officers in 2024. Say-on-Pay |
Board | For | FOR 61 funds |
AGAINST 18 funds |
| INTERROLL HOLDING AG | June 6, 2025 | Appoint Susanne Schreiber as Member of the Compensation Committee Director Elections |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| INTERROLL HOLDING AG | June 6, 2025 | Reelect Ingo Specht as Director Director Elections |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| INTERROLL HOLDING AG | June 6, 2025 | Reelect Stefano Mercorio as Director Director Elections |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| INTERROLL HOLDING AG | June 6, 2025 | Reelect Susanne Schreiber as Director Director Elections |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| INTRA-CELLULAR THERAPIES INC. | March 27, 2025 | To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to ITI's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement. Say-on-Pay |
Board | For | FOR 39 funds |
AGAINST 4 funds |
| IQVIA HOLDINGS INC. | April 24, 2025 | Approve an advisory (non-binding) resolution to approve IQVIA's executive compensation (say-on-pay). Say-on-Pay |
Board | For | FOR 65 funds |
AGAINST 22 funds |
| IROBOT CORP. | May 16, 2025 | Approve an amendment to the iRobot Corporation 2018 Stock Option and Incentive Plan, as amended (the "2018 Plan"), to increase the maximum number of shares reserved for issuance under the 2018 Plan. Compensation |
Board | For | FOR 7 funds |
AGAINST 12 funds |
| IROBOT CORP. | May 16, 2025 | Approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 14 funds |
AGAINST 13 funds |
| IRONWOOD PHARMACEUTICALS INC. | June 10, 2025 | Approval, by non-binding advisory vote, of the compensation paid to the named executive officers. Say-on-Pay |
Board | For | FOR 22 funds |
AGAINST 1 fund |
| ISRACARD LTD | July 11, 2024 | APPROVE GRANT OF UNREGISTERED OPTIONS TO RAN OZ, CEO Compensation |
Board | For | FOR 19 funds |
AGAINST 1 fund |
| ISRAEL DISCOUNT BANK LTD. | November 28, 2024 | ELECT KEREN KIBOVICH AS DIRECTOR Director Elections |
Board | For | ABSTAIN 17 funds |
FOR 2 funds |
| ISRAEL DISCOUNT BANK LTD. | November 28, 2024 | ELECT REUVEN ADLER AS DIRECTOR Director Elections |
Board | For | FOR 17 funds |
ABSTAIN 2 funds |
| ISS A/S | April 11, 2025 | Authorize Share Repurchase Program Capital Structure |
Board | For | FOR 9 funds |
AGAINST 11 funds |
| ITALMOBILIARE SPA | April 17, 2025 | Approve Remuneration Policy Compensation |
Board | For | FOR 2 funds |
AGAINST 4 funds |
| ITERIS INC. | October 22, 2024 | To approve, on a non binding, advisory basis, certain compensation that will or may become payable to Iteris, Inc.'s named executive officers in connection with the transactions contemplated by the Merger Agreement. Say-on-Pay |
Board | For | FOR 11 funds |
AGAINST 17 funds |
| ITT INC. | May 21, 2025 | Approval of a non-binding advisory vote on executive compensation Say-on-Pay |
Board | For | FOR 47 funds |
AGAINST 16 funds |
| IZEA WORLDWIDE INC. | December 12, 2024 | To approve an amendment to IZEA's Amended and Restated 2011 Equity Incentive Plan. Compensation |
Board | For | FOR 1 fund |
AGAINST 5 funds |
| JANUS INTE | June 16, 2025 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | Not determined | FOR 21 funds |
AGAINST 1 fund |
| JBG SMITH PROPERTIES | April 24, 2025 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement ("Say-on-Pay"). Say-on-Pay |
Board | For | FOR 32 funds |
AGAINST 5 funds |
| JEFFERIES | March 27, 2025 | Advisory vote to approve 2024 executive-compensation program. Say-on-Pay |
Board | Not determined | FOR 48 funds |
AGAINST 20 funds |
| JELD-WEN HOLDING INC. | April 24, 2025 | To approve the amended and restated 2017 Omnibus Equity Plan. Compensation |
Board | For | FOR 21 funds |
AGAINST 20 funds |
| JERASH HOLDINGS (US) INC. | September 27, 2024 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 3 funds |
| JONES LANG LASALLE INC. | May 21, 2025 | Approval, on an advisory basis, of JLL's Executive Compensation ("Say On Pay") Say-on-Pay |
Board | For | FOR 51 funds |
AGAINST 25 funds |
| KALVISTA PHARMACEUTICALS INC. | October 3, 2024 | Approval, on a non-binding advisory basis, of the compensation paid by us to our named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 14 funds |
AGAINST 13 funds |
| KATAPULT HOLDINGS INC. | June 4, 2025 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| KBC GROUP SA/NV | April 30, 2025 | Approve Co-optation of Bartel Puelinckx as Director Director Elections |
Board | For | FOR 24 funds |
AGAINST 14 funds |
| KBC GROUP SA/NV | April 30, 2025 | Elect Michiel Allaerts as Director Director Elections |
Board | For | FOR 24 funds |
AGAINST 14 funds |
| KEMPER CORP. | May 7, 2025 | Advisory vote to approve the compensation of the Company's Named Executive Officers. Say-on-Pay |
Board | For | FOR 36 funds |
AGAINST 20 funds |
| KENNEDY-WILSON HOLDINGS INC. | June 5, 2025 | To approve an amendment to the Company's Second Amended and Restated 2009 Equity Participation Plan to increase the number of shares of the Company's common stock that may be issued thereunder by an additional 3,400,000 shares. Compensation |
Board | For | FOR 19 funds |
AGAINST 9 funds |
| KEROS THERAPEUTICS INC. | June 4, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying Proxy Statement. Say-on-Pay |
Board | For | FOR 17 funds |
AGAINST 1 fund |
| KEYCORP | May 15, 2025 | Advisory approval of executive compensation. Say-on-Pay |
Board | For | FOR 54 funds |
AGAINST 18 funds |
| KINEPOLIS GROUP NV | May 14, 2025 | Approve Remuneration Policy Compensation |
Board | For | FOR 1 fund |
AGAINST 9 funds |
| KINGSTONE COMPANIES INC. | August 7, 2024 | To hold a non-binding advisory vote to approve the Company's executive compensation. Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 12 funds |
| KLX ENERGY SERVICES HOLDINGS INC. | May 7, 2025 | To approve, on an advisory, non-binding basis, the compensation of the Company's named executive officers; Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 4 funds |
| KODIAK SCIENCES INC. | June 2, 2025 | Approve, on an advisory basis, the compensation of Kodiak's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 13 funds |
AGAINST 8 funds |
| KOHL'S CORP. | May 14, 2025 | To approve, by an advisory vote, the compensation of our Named Executive Officers. Say-on-Pay |
Board | For | FOR 36 funds |
AGAINST 17 funds |
| KONE OYJ | March 5, 2025 | Approve Remuneration Report (Advisory Vote) Compensation |
Board | For | FOR 1 fund |
AGAINST 11 funds |
| KONGSBERG GRUPPEN ASA | May 7, 2025 | APPROVE EQUITY PLAN FINANCING Compensation |
Board | For | FOR 31 funds |
AGAINST 10 funds |
| KONGSBERG GRUPPEN ASA | May 7, 2025 | REELECT EIVIND REITEN AS DIRECTOR Director Elections |
Board | For | AGAINST 31 funds |
FOR 10 funds |
| KONGSBERG GRUPPEN ASA | May 7, 2025 | REELECT MORTEN HENRIKSEN AS DIRECTOR Director Elections |
Board | For | FOR 31 funds |
AGAINST 10 funds |
| KOPPERS HOLDINGS INC. | May 8, 2025 | PROPOSAL TO APPROVE OUR AMENDED AND RESTATED 2020 LONG TERM INCENTIVE PLAN Compensation |
Board | For | FOR 16 funds |
AGAINST 20 funds |
| KORU MEDICAL SYSTEMS INC. | May 14, 2025 | Approval, on an advisory basis, of the compensation of the Company's executive officers. Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 6 funds |
| KRONOS WORLDWIDE INC. | May 14, 2025 | Nonbinding advisory vote approving named executive officer compensation. Say-on-Pay |
Board | For | FOR 16 funds |
AGAINST 18 funds |
| KUEHNE + NAGEL INTERNATIONAL AG | May 7, 2025 | APPOINT TOBIAS STAEHELIN AS MEMBER OF THE COMPENSATION COMMITTEE Corporate Governance |
Board | For | FOR 30 funds |
AGAINST 6 funds |
| KUEHNE + NAGEL INTERNATIONAL AG | May 7, 2025 | REELECT JOERG WOLLE AS BOARD CHAIR Director Elections |
Board | For | AGAINST 30 funds |
FOR 6 funds |
| KUEHNE + NAGEL INTERNATIONAL AG | May 7, 2025 | REELECT JOERG WOLLE AS DIRECTOR Corporate Governance |
Board | For | AGAINST 30 funds |
FOR 6 funds |
| KURA ONCOLOGY INC. | June 5, 2025 | Approval of an amendment to our Amended and Restated 2014 Equity Incentive Plan. Compensation |
Board | For | FOR 16 funds |
AGAINST 8 funds |
| L3HARRIS T | April 18, 2025 | Approval, in an Advisory Vote, of the Compensation of Named Executive Officers as Disclosed in the Proxy Statement. Say-on-Pay |
Board | Not determined | FOR 59 funds |
AGAINST 17 funds |
| LA COMER SAB DE CV | April 9, 2025 | Approve Allocation of Income and Maximum Amount for Repurchase of Shares Capital Structure |
Board | For | FOR 3 funds |
AGAINST 4 funds |
| LANTRONIX INC. | November 5, 2024 | To approve, on a non-binding advisory basis, the compensation paid to our named executive officers as described in the proxy statement accompanying this notice. Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 19 funds |
| LATAM AIRLINES GROUP SA | March 17, 2025 | Authorize Board to Repurchase Shares without Applying Prorate Procedure Capital Structure |
Board | For | AGAINST 12 funds |
FOR 3 funds |
| LATAM AIRLINES GROUP SA | March 17, 2025 | Authorize Board to Sell Repurchased Shares without Applying Preemptive Rights Capital Structure |
Board | For | AGAINST 12 funds |
FOR 3 funds |
| LATAM AIRLINES GROUP SA | March 17, 2025 | Authorize Share Repurchase Program Capital Structure |
Board | For | AGAINST 12 funds |
FOR 3 funds |
| LATAM AIRLINES GROUP SA | March 17, 2025 | Set Maximum Amount or Percentage to be Acquired, Objective and Duration of Share Repurchase Program Capital Structure |
Board | For | AGAINST 12 funds |
FOR 3 funds |
| LAZARD INC. | May 8, 2025 | Non-binding advisory vote regarding executive compensation. Say-on-Pay |
Board | For | FOR 38 funds |
AGAINST 15 funds |
| LCI INDUSTRIES | May 15, 2025 | To approve, in a non-binding advisory vote, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 28 funds |
AGAINST 22 funds |
| LEAP THERAPEUTICS INC. | July 2, 2024 | Advisory vote on executive compensation paid to named executive officers ("Say-on-Pay Proposal"). Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 10 funds |
| LEE ENTERPRISES INC. | February 27, 2025 | Approve to amend the 2020 Long-Term Incentive Plan. Compensation |
Board | For | FOR 1 fund |
AGAINST 5 funds |
| LEM HOLDING SA | June 26, 2025 | Reelect Ulrich Looser as Director Director Elections |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| LEM HOLDING SA | June 26, 2025 | Reelect Werner Weber as Director Director Elections |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| LEMON TREE HOTELS LTD | September 26, 2024 | TO APPROVE GRANT OF STOCK APPRECIATION RIGHTS TO THE EMPLOYEES OF GROUP COMPANY(IES) INCLUDING SUBSIDIARY COMPANY, ITS ASSOCIATE COMPANY AND/OR HOLDING COMPANY (IES), IN INDIA OR OUTSIDE INDIA UNDER LTHL STOCK APPRECIATION RIGHTS SCHEME - 2024 Compensation |
Board | For | AGAINST 3 funds |
FOR 2 funds |
| LENNAR CORP. | April 9, 2025 | Approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 53 funds |
AGAINST 19 funds |
| LEXICON PHARMACEUTICALS INC. | June 2, 2025 | Advisory vote to approve the compensation paid to the Company's named executive officers Say-on-Pay |
Board | For | FOR 13 funds |
AGAINST 1 fund |
| LIFE360 INC. | May 27, 2025 | Non-binding, advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 22 funds |
AGAINST 4 funds |
| LIFETIME BRANDS INC. | June 18, 2025 | TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE 2024 COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| LIFEVANTAGE CORP. | November 7, 2024 | To approve a non-binding, advisory resolution approving the compensation of our named executive officers; Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 18 funds |
| LIGHT & WONDER INC. | June 10, 2025 | To approve an amendment and restatement of the Company's 2003 Incentive Compensation Plan to increase the number of shares of stock authorized for issuance thereunder. Compensation |
Board | For | FOR 23 funds |
AGAINST 1 fund |
| LIMONEIRA CO. | April 9, 2025 | To vote on an advisory resolution to approve the compensation of the Named Executive Officers as disclosed in this proxy statement ("Proposal 2"). Say-on-Pay |
Board | For | FOR 13 funds |
AGAINST 19 funds |
| LINCOLN NATIONAL CORP. | May 22, 2025 | The approval of an amendment to the Lincoln National Corporation 2020 Incentive Compensation Plan. Compensation |
Board | For | FOR 21 funds |
AGAINST 14 funds |
| LINDBLAD EXPEDITIONS HOLDINGS INC. | June 4, 2025 | The approval of an amendment to the Lindblad Expeditions Holdings, Inc. 2021 Long-Term Incentive Plan. Compensation |
Board | For | FOR 12 funds |
AGAINST 5 funds |
| LINDBLAD EXPEDITIONS HOLDINGS INC. | June 4, 2025 | The approval, on an advisory basis, of the 2024 compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 21 funds |
AGAINST 6 funds |
| LINEA DIRECTA ASEGURADORA SA | April 10, 2025 | Reelect Alfonso Botin-Sanz de Sautuola y Naveda as Director Director Elections |
Board | For | FOR 7 funds |
AGAINST 8 funds |
← Previous Page 6 of 14 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 18, 2026 from SEC Form N-PX filings.